From UCSF Magazine: Neurosurgeon Shawn Hervey-Jumper, MD, specializes in awake brain surgery, in which patients are alert and engaged during parts of the procedure in order to prevent severe brain damage. [read more]
|
|
|
|
In the latest CureTalks podcast, Dr. Lawrence Fong joins patient advocates to discuss the advantages and challenges of harnessing the power of cellular therapy. |
|
|
|
From UCSF Magazine: Dr. Pamela Ling applies her research-driven social media and marketing expertise to beat the tobacco industry at its own game – and avoid similar pitfalls with cannabis. |
|
Funding Opportunity: The Cancer League |
|
|
|
The Helen Diller Family Comprehensive Cancer Center has been invited by The Cancer League to submit requests for funding. The Cancer League’s primary interest is in funding projects in early stage research and/or supporting and assisting patients through their cancer journey. Learn more and apply by Feb 1.
|
|
The Helen Diller Family Comprehensive Cancer Center was named a top oncology hospital by Becker's Hospital Review.
Xu Chen, PhD received an R01 funded by the NCI for a project, "Targeting Gq pathway in uveal melanoma."
Xu Chen, PhD received an R01 funded by the NCI for a project, "RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma."
A. Hunter Shain, PhD received an R01 funded by the NCI for a project, "The genomic landscape and evolution of cutaneous squamous cell carcinoma."
Xu Chen, PhD received a Department of Defense (DOD) Idea Development Award for a project, "Identifying Novel Therapeutic Strategies for Metastatic Uveal Melanoma."
|
|
Kuzuoglu-Ozturk D, Aksoy O, Schmidt C, Lea R, Larson JD, Phelps RRL, Nasholm N, Holt M, Contreras A, Huang M, Wong-Michalak S, Shao H, Wechsler-Reya R, Phillips JJ, Gestwicki JE, Ruggero D, Weiss WA. N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Res. 2023 Jan 4;83(1):130-140.
Huppert LA, Walker Z, Li M, Kim MO, Callan J, Brandman D, Majure M, Melisko ME, Rugo HS, Behr S, Chien AJ. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Res Treat. 2023 Jan;197(1):137-148.
Nyberg WA, Ark J, To A, Clouden S, Reeder G, Muldoon JJ, Chung JY, Xie WH, Allain V, Steinhart Z, Chang C, Talbot A, Kim S, Rosales A, Havlik LP, Pimentel H, Asokan A, Eyquem J. An evolved AAV variant enables efficient genetic engineering of murine T cells. Cell. 2023 Jan 5:S0092-8674(22)01535-5. |
|
Cervical cancer is preventable, treatable, and beatable. Last month, HDFCCC's Office of Community Engagement (OCE) staff and partners launched a campaign to raise awareness of cervical cancer, screening, and HPV vaccination through community events, website, and social media posts.
|
|
|
This three-day conference features tracks on Emerging Therapeutics, AI & Data Sciences, Diagnostics & Molecular Profiling in the Clinic, and Next Generation Technologies.
Please join Dr. Hope Rugo and Dr. Saya Jacob as they share updates from the San Antonio Breast Cancer Symposium (SABCS) that took place in December.
This year's tobacco symposium features a keynote panel on "20 Years of the Industry Documents: Past, Present and Future."
In this hybrid symposium for patients and caregivers, learn practical tips and approaches to get the most out of your care, while also learning about emerging melanoma research.
|
|
|
|
|
|
|
